Mid-cap Healthcare company Elanco Animal Health has moved -1.1% so far today on a volume of 3,853,358, compared to its average of 7,009,767. In contrast, the S&P 500 index moved 0.4%.
Elanco Animal Health trades -25.0% away from its average analyst target price of $17.44 per share. The 9 analysts following the stock have set target prices ranging from $12 to $23, and on average have given Elanco Animal Health a rating of hold.
If you are considering an investment in ELAN, you'll want to know the following:
-
Elanco Animal Health has moved -51.2% over the last year, and the S&P 500 logged a change of -12.6%
-
Based on its trailing earnings per share of -0.75, Elanco Animal Health has a trailing 12 month Price to Earnings (P/E) ratio of -17.5 while the S&P 500 average is 15.97
-
ELAN has a forward P/E ratio of 12.8 based on its forward 12 month price to earnings (EPS) of $1.02 per share
-
The company has a price to earnings growth (PEG) ratio of 1.4 — a number near or below 1 signifying that Elanco Animal Health is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 0.9 compared to its sector average of 4.07
-
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.
-
Based in Greenfield, the company has 9,000 full time employees and a market cap of $6,202,601,472.